Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
The downside that can come from buying these securities is precisely why we started StockStory - to isolate the long-term winners from the losers so you can invest with confidence. Keeping that in mind, here is one small-cap stock that could be the next big thing and two that could be down big.
Two Small-Cap Stocks to Sell:
Carter's (CRI)
Market Cap: $1.15 billion
Rumored to sell more than 10 products for every child born in the United States, Carter's (NYSE: CRI) is an American designer and marketer of children's apparel.
Why Do We Avoid CRI?
- Poor same-store sales performance over the past two years indicates it’s having trouble bringing new shoppers into its stores
- Free cash flow margin is forecasted to shrink by 1.3 percentage points in the coming year, suggesting the company will consume more capital to keep up with its competitors
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
Carter’s stock price of $31.32 implies a valuation ratio of 8.9x forward P/E. Read our free research report to see why you should think twice about including CRI in your portfolio.
Prosperity Bancshares (PB)
Market Cap: $7.96 billion
With a network of banking centers spanning the Lone Star State and beyond, Prosperity Bancshares (NYSE: PB) operates full-service banking locations throughout Texas and Oklahoma, offering a wide range of financial products and services to businesses and consumers.
Why Are We Bearish on PB?
- Net interest income trends were unexciting over the last five years as its 3.4% annual growth was below the typical banking firm
- Incremental sales over the last five years were less profitable as its 1% annual earnings per share growth lagged its revenue gains
- Capital strength will likely plateau over the next 12 months as Wall Street expects flat tangible book value per share
At $65.74 per share, Prosperity Bancshares trades at 0.8x forward P/B. If you’re considering PB for your portfolio, see our FREE research report to learn more.
One Small-Cap Stock to Buy:
Clover Health (CLOV)
Market Cap: $2.29 billion
Founded in 2014 to improve healthcare for America's seniors through technology, Clover Health (NASDAQ: CLOV) provides Medicare Advantage plans for seniors with a focus on affordable care and uses its proprietary Clover Assistant software to help physicians manage patient care.
Why Do We Love CLOV?
- Annual revenue growth of 36.9% over the past two years was outstanding, reflecting market share gains this cycle
- Earnings per share grew by 15.2% annually over the last five years, massively outpacing its peers
- Free cash flow turned positive over the last five years, indicating the company has achieved financial self-sustainability
Clover Health is trading at $4.34 per share, or 28.8x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
